Can InMode Convince Anyone the Go-Private Offer Won't Overshadow Tomorrow's Print?

InMode Ltd. (NASDAQ: INMD) reports Q2 2026 earnings before market open on August 5, 2026, with investors focused on whether the medical aesthetics technology provider can sustain the momentum from its recent revenue beat while navigating persistent margin pressure. The company's ability to demonstrate improving profitability amid a challenging operating environment will be critical, as Wall Street weighs signs of stabilization against lingering concerns about the pace of recovery in its core markets.

Part 1: Earnings Preview

InMode is a leading global provider of innovative medical technology platforms for minimally invasive aesthetic and surgical procedures, specializing in radiofrequency-based devices used in dermatology, plastic surgery, and gynecology. The company's product portfolio includes platforms like BodyTite, Morpheus8, and Evoke, which address body contouring, skin rejuvenation, and facial remodeling.

InMode is scheduled to report Q2 2026 results before the market opens on Thursday, August 5, with analysts expecting $0.33 EPS on $93.0 million in revenue. The company most recently reported $0.34 EPS for Q3 2025. Comparing to the same quarter last year (Q2 2025), when InMode posted $0.42 EPS, the current estimate implies a 21% year-over-year decline in earnings, reflecting ongoing headwinds in the business.

Three key themes define this earnings story:

Revenue Stabilization vs. Margin Recovery: InMode delivered a mixed Q1 2026 result in May, with revenue of $82.0 million beating estimates and rising 5.3% year over year, but EPS of $0.25 missing the $0.30 consensus. The question now is whether the company can maintain its revenue trajectory while improving profitability—management's full-year guidance calls for revenues between $365 million and $375 million with non-GAAP operating margins of 74-76%, but gross margins compressed to 75% in Q1 from 78% a year earlier.

Operating Leverage and Cost Management: With GAAP operating margins falling to just 12% in Q1 2026 from 20% a year earlier, investors are watching closely for signs that InMode can translate revenue growth into bottom-line improvement. The company's non-GAAP operating income of $14.0 million in Q1 represented a significant decline from prior periods, and management's full-year guidance for non-GAAP operating income of $73-78 million implies the need for substantial sequential improvement.

Market Demand and Competitive Positioning: InMode's recent revenue beat suggests some stabilization in demand for aesthetic procedures, but the company faces questions about the sustainability of growth in a competitive market. The 5.3% year-over-year revenue increase in Q1 marked an improvement from recent trends, but analysts remain cautious about whether this represents a genuine inflection point or temporary strength.

Heading into the release, Wall Street sentiment is mixed. Barclays maintains an "overweight" rating with a $19 price target, expressing confidence in the company's long-term positioning. However, Robert W. Baird recently lowered its target from $17 to $14 with a "neutral" rating following the Q1 miss, citing concerns about the pace of margin recovery. The consensus view reflects this caution, with a Hold rating across six analysts and an average price target of $16.25, implying modest upside from current levels but limited conviction in a near-term breakout.

Part 2: Historical Earnings Performance

InMode has delivered a mixed earnings track record over the past four quarters, with results alternating between beats and misses. In Q4 2024, the company reported $0.38 EPS against a $0.45 estimate, missing by 15.56%. Q1 2025 saw another miss, with $0.26 EPS versus $0.28 expected, a 7.14% shortfall. The trend reversed in Q2 2025, when InMode beat with $0.42 EPS against a $0.38 estimate, a 10.53% positive surprise. Most recently, Q3 2025 delivered $0.34 EPS, though no estimate was available for comparison.

The pattern reveals inconsistent execution rather than a clear directional trend. The company has missed estimates in two of the three quarters where comparisons are available, with the misses ranging from 7% to 16%. The single beat of 10.53% in Q2 2025 was meaningful but hasn't established a pattern of consistent outperformance. This volatility in results relative to expectations suggests InMode is navigating a challenging operating environment where visibility remains limited, making the upcoming Q2 2026 report particularly important for establishing whether the Q1 2026 revenue beat signals genuine stabilization or represents another data point in an erratic pattern.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

InMode typically reports earnings before market open, meaning Day 0 represents the first trading session where investors react to results, while Day +1 captures follow-through momentum.

InMode's post-earnings price behavior shows moderate volatility with a bearish bias. Over the past eight earnings releases, the stock has averaged an absolute Day 0 move of 4.79% with an intraday range of 6.11%, indicating meaningful initial reactions. Day +1 follow-through averages 2.39% with a 4.63% range, suggesting continued volatility into the second session.

The directional pattern leans negative, with several notable declines: the most recent report on May 6, 2026 saw a 5.63% drop on Day 0, while the August 1, 2024 release triggered an 8.55% decline. The April 28, 2025 report produced the most extreme reaction, with a **12.08% Day 0 plunge. However, the stock has also shown capacity for sharp rallies, including a 4.98% Day 0 gain in February 2025.

Investors should anticipate a mid-single-digit percentage move on the day of the report, with potential for larger swings if results or guidance deviate significantly from expectations. The historical pattern suggests the initial reaction tends to be more pronounced than the follow-through, though multi-day volatility remains elevated relative to normal trading.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 1.66% for the August 21 expiration, significantly below the stock's average historical Day 0 move of 4.79% and even its Day +1 average of 2.39%. This suggests options traders are anticipating a relatively muted reaction to Q2 results, potentially reflecting reduced conviction or expectations for an in-line report.

Part 3: What Analysts Are Saying

Wall Street maintains a cautious stance on InMode heading into Q2 earnings, with a consensus rating of 3.33 (Hold) and an average price target of $16.25. The analyst community consists of 1 Strong Buy, 5 Holds, and 0 Sells, reflecting limited conviction in either direction. The price target range spans from a low of $14.00 to a high of $19.00, indicating divergent views on the company's near-term prospects.

Analyst sentiment has improved modestly over the past month, with the average recommendation ticking up from 3.29 to 3.33 and one analyst shifting from Hold to a more constructive stance. However, the overall posture remains neutral, with the majority of coverage maintaining Hold ratings as they await evidence of sustained margin improvement and clearer visibility into the demand environment.

From the current price of $15.38, the consensus target of $16.25 implies 5.7% upside, a modest premium that reflects Wall Street's wait-and-see approach. The high-end target of $19.00 would represent 23.5% upside, suggesting meaningful potential if InMode can demonstrate accelerating revenue growth and margin expansion. Conversely, the low-end target of $14.00 sits 9.0% below current levels, indicating downside risk if execution falters or guidance disappoints.

Part 4: Technical Picture

InMode enters earnings with strengthening technical momentum after a sustained period of consolidation. The Barchart Technical Opinion currently stands at 88% Buy, up sharply from 72% Buy a week ago and 24% Buy a month ago, signaling rapidly improving technical conditions as the stock breaks out of its recent range.

Timeframe Analysis:

• Short-term (100% Buy): Maximum bullish signal indicates strong near-term momentum heading into the earnings release
• Medium-term (100% Buy): Equally strong reading confirms the breakout is supported across intermediate timeframes, not just short-term noise
• Long-term (50% Buy): Moderate bullish signal suggests the longer-term trend is improving but not yet fully established

Strong Strongest trend characteristics indicate InMode is experiencing its most robust technical setup in recent months, with momentum accelerating across multiple timeframes as earnings approach.

The stock is trading at $15.38, positioned above all key moving averages: the 5-day ($15.22), 10-day ($15.24), 20-day ($15.22), 50-day ($14.43), 100-day ($14.18), and 200-day ($14.36). This complete alignment above moving averages confirms the technical breakout is broad-based, with the stock reclaiming key resistance levels that had capped rallies earlier in the year.

The 52-week range of $12.72 to $16.74 shows InMode trading in the upper portion of its annual range, with the current price just 8.8% below the high. The recent surge above all moving averages, combined with the strongest technical opinion reading in months, suggests the stock is entering earnings with supportive momentum. However, the proximity to the 52-week high and the rapid improvement in technical signals also means the setup is vulnerable to profit-taking if results or guidance disappoint, particularly given the stock's history of volatile post-earnings reactions.